Article: Hormonal therapy in climacteric women: compliance and its socioeconomic impact

Hormonal therapy can effectively enhance the quality of life for postmenopausal women, and prevent climacteric-related conditions such as osteoporosis. Since long-term therapy is often required, compliance becomes an important issue. This can best be achieved by measurement, documenting the reason for hormone therapy, and by repeated measurement, demonstrating a response to the treatment. Case histories documenting this principle are described.

Citing Articles

Contraceptives or Hormone Replacement Therapy and Associations with Autoimmune Conditions: Exploring Effects of Estrogen Analog Supplementation.

Tskhakaia I, Gonzalez Moret Y, Palmer A, Lema D, Musri M, Tsibadze N ACR Open Rheumatol. 2024; 7(1):e11774.

PMID: 39658932 PMC: 11707263. DOI: 10.1002/acr2.11774.

References

1.

Ballinger C . Psychiatric morbidity and the menopause; screening of general population sample. Br Med J. 1975; 3(5979):344-6. PMC: 1673831. DOI: 10.1136/bmj.3.5979.344. View

2.

Campbell S, Whitehead M . Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol. 1977; 4(1):31-47. View

3.

NOTELOVITZ M . The role of the gynecologist in osteoporosis prevention: a clinical approach. Clin Obstet Gynecol. 1987; 30(4):871-82. DOI: 10.1097/00003081-198712000-00010. View

4.

WEINSTEIN L . Efficacy of a continuous estrogen-progestin regimen in the menopausal patient. Obstet Gynecol. 1987; 69(6):929-32. View

5.

NOTELOVITZ M . Post-menopausal osteoporosis. A practical approach to its prevention. Acta Obstet Gynecol Scand Suppl. 1986; 134:67-80. DOI: 10.3109/00016348609157053. View

6.

Ballinger C . Psychiatric morbidity and the menopause: survey of a gynaecological out-patient clinic. Br J Psychiatry. 1977; 131:83-9. DOI: 10.1192/bjp.131.1.83. View

7.

Tulandi T, Lal S . Menopausal hot flush. Obstet Gynecol Surv. 1985; 40(9):553-63. DOI: 10.1097/00006254-198509000-00002. View

8.

Ettinger B, Genant H, Cann C . Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985; 102(3):319-24. DOI: 10.7326/0003-4819-102-3-319. View

9.

Weiss N, Ure C, Ballard J, Williams A, Daling J . Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980; 303(21):1195-8. DOI: 10.1056/NEJM198011203032102. View

10.

SCHIFF I, Tulchinsky D, Cramer D, Ryan K . Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA. 1980; 244(13):1443-5. View

11.

SCHIFF I, Regestein Q, Tulchinsky D, Ryan K . Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA. 1979; 242(22):2405-4. View

12.

Padwick M, PRYSE-DAVIES J, Whitehead M . A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens. N Engl J Med. 1986; 315(15):930-4. DOI: 10.1056/NEJM198610093151504. View

Hormonal Therapy in Climacteric Women: Compliance and Its Socioeconomic Impact